Haliodx
FranceWho owns Haliodx?
Haliodx is a French Healthcare company, now owned by Veracyte, which acquired it in 2021 from Turenne Groupe and SOFIPACA - Groupe Crédit Agricole.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Key facts
- ·Fully exited in 2021 to Veracyte.
- ·Average hold across 2 realized cycles: 5 years.
Ownership history
2 ownership periods · co-invest detected
Turenne Groupe sold HALIODX to Veracyte in 2021 after 6 years.
SOFIPACA - Groupe Crédit Agricole sold HalioDx to Veracyte in 2021 after 3 years.
More from Capital Santé 2
Other portfolio companies in the same fund.
More PE-backed in Healthcare
Comparable healthcare deals from other GPs.
US
Questions
Who owns Haliodx?
Haliodx is now owned by Veracyte, which acquired it in 2021 from Turenne Groupe and SOFIPACA - Groupe Crédit Agricole.
When did Veracyte acquire Haliodx?
Veracyte acquired Haliodx in 2021, buying from Turenne Groupe and SOFIPACA - Groupe Crédit Agricole.
Who did Haliodx sell to?
Turenne Groupe and SOFIPACA - Groupe Crédit Agricole sold Haliodx to Veracyte in 2021 (Trade Sale).
Who has owned Haliodx over time?
Haliodx has been through 2 private-equity ownership periods: Turenne Groupe · via Capital Santé 2 · 2015–2021 · sold to Veracyte · (Trade Sale); SOFIPACA - Groupe Crédit Agricole · via SOFIPACA Evergreen · 2018–2021 · sold to Veracyte · (Trade Sale).